The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma
Authors
Keywords
Dexamethasone, Multiple myeloma, eIF2 signaling, Apoptosis
Journal
LEUKEMIA RESEARCH
Volume 55, Issue -, Pages 23-32
Publisher
Elsevier BV
Online
2017-01-13
DOI
10.1016/j.leukres.2017.01.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.